Synageva Biopharma (GEVA) Earnings
|
Expand Research on GEVA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -6.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/26/15 |
Q114 | -$1.73 | -$1.71 | -$0.02 | N/A | $1.37M | N/A | ![]() | ![]() | Details | |
| 3/3/14 | Q413 | -$1.00 | N/A | N/A | $3.47M | $4.88M | N/A | ![]() | ![]() | Details | |
| 10/29/13 | Q313 | -$1.02 | -$0.89 | -$0.13 | $1.05M | $2.81M | N/A | ![]() | ![]() | Details | |
| 8/5/13 | Q113 | -$0.81 | -$0.76 | -$0.05 | $3.41M | $2.9M | N/A | ![]() | ![]() | Details | |
| 3/11/13 | Q412 | -$0.62 | -$0.60 | -$0.02 | $2M | $2.32M | N/A | ![]() | ![]() | Details | |
| 3/15/12 |
Q411 | -$0.65 | -$0.38 | -$0.27 | $1.61M | $1.78M | N/A | ![]() | ![]() | Details |


